Nuclear-Envelope Nucleoside Triphosphatase Kinetics and mRNA Transport Following Brain Ischemia and Reperfusion - 12/09/11
Abstract |
Study hypothesis: We attempted to determine whether the reduced egress of mRNA from brain nuclei following in vivo ischemia and reperfusion is caused by direct damage to the nuclear pore–associated NTPase that impairs the system for nuclear export of polyadenylated, or poly (A)+, mRNA.
Design: Prospective animal study. Interventions: NTPase activity and poly(A)+ mRNA transport were studied in nuclear envelope vesicles (NEVs) prepared from canine parietal cortex isolated after 20 minutes of ischemia or 20 minutes of ischemia and 2 or 6 hours of reperfusion. Results: Brain NEV NTPase Michaelis-Menten constant (Km) and maximum uptake velocity (Vmax) and the ATP-stimulated poly(A)+ mRNA egress rates were not significantly affected by ischemia and reperfusion. In vitro exposure of the NEVs to the OH× radical–generating system completely abolished NTPase activity. Conclusion: We conclude that brain ischemia and reperfusion do not induce direct inhibition of nucleocytoplasmic transport of poly(A)+ mRNA. This suggests that the nuclear membrane is not exposed to significant concentrations of OH× radical during reperfusion. [Tiffany BR, White BC, Krause GS: Nuclear-envelope nucleoside triphosphatase kinetics and mRNA transport following brain ischemia and reperfusion. Ann Emerg Med June 1995;25:809-817.]
Le texte complet de cet article est disponible en PDF.Plan
| From the Department of Emergency Medicine, Wayne State University, Detroit, Michigan. |
|
| This work was supported by grant 07G934 from the American Heart Association of Michigan. Dr. Tiffany was supported by a fellowship grant from the Emergency Medicine Foundation and Eli Lilly & Co. |
|
| Address for reprints: Gary Krause, MD, MS, Department of Emergency Medicine, Wayne State University, 4201 St Antoine, Detroit, Michigan 48201, 313-577-3187, Fax 313-745-3653 |
|
| Reprint no. 47/1/63453 |
Vol 25 - N° 6
P. 809-817 - juin 1995 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
